+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Efficacy Testing - Global Market Trajectory & Analytics

  • ID: 4804344
  • Report
  • February 2022
  • Region: Global
  • 689 Pages
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • bioMérieux
  • Eurofins Scientific SE
  • Merck KGaA
  • Pacific Biolabs Inc.
  • SGS S.A
  • WuXi AppTec

Global Efficacy Testing Market to Reach $796.7 Million by 2026


Efficacy test evaluates the effectiveness of the product through a series of tests, including safety test, toxicology test, and stability test, in order to get better quantitative values in addition to proof of efficacy and safety, after which the product becomes suitable for commercialization. Growth in the global market is being driven by regulations for the safety and efficacy of pharmaceutical products. Increasing support from governments across the world for pharmaceutical and biotechnology industries, coupled with increasing investments for research and development activities in these sectors contributes to market growth. Moreover, the growing application of antimicrobial efficacy testing for different types of medical devices, in cosmetic and pharmaceutical industries, and R&D investments in the life sciences space are anticipated to boost the market.

Amid the COVID-19 crisis, the global market for Efficacy Testing estimated at US$425.4 Million in the year 2020, is projected to reach a revised size of US$796.7 Million by 2026, growing at a CAGR of 10.7% over the analysis period. Consumables, one of the segments analyzed in the report, is projected to record a 11.4% CAGR and reach US$503.4 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 9.6% CAGR for the next 7-year period. Market growth is dominated by the consumables segment, which is attributed to continual demand for bulk procurement and regular purchases of consumables.



The U.S. Market is Estimated at $149.1 Million in 2021, While China is Forecast to Reach $107.7 Million by 2026


The Efficacy Testing market in the U.S. is estimated at US$149.1 Million in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$107.7 Million by the year 2026 trailing a CAGR of 12.3% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8% and 9.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.4% CAGR. The US dominates market growth due to heavy investments into research and development by several pharmaceutical vendors. Demand for efficacy testing in the US is further driven by stringent regulations for drug development, and increasing government funding for research activities in the area of life sciences. Growth in the Asia-Pacific region is attributed to the rising demand for pharmaceuticals in the region. Factors such as the rising geriatric population, growing incidence of chronic diseases, increasing consumer health awareness, and increased government expenditure on the region`s healthcare infrastructure as well as quality control safety testing outsourcing in the Asian countries.

Services Segment to Reach $112 Million by 2026


In the global Services segment, USA, Canada, Japan, China and Europe will drive the 9.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$50.9 Million in the year 2020 will reach a projected size of US$98.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$9.5 Million by the year 2026, while Latin America will expand at a 11.2% CAGR through the analysis period.

Select Competitors (Total 70 Featured) -

  • Eurofins Scientific SE
  • Merck KGaA
  • WuXi AppTec
  • SGS S.A
  • bioMérieux
  • Charles River Laboratories Inc.
  • Pacific Biolabs Inc.
Frequently Asked Questions about the Global Market for Efficacy Testing

What is the estimated value of the Global Market for Efficacy Testing?

The Global Market for Efficacy Testing was estimated to be valued at $425.4 Million in 2020.

What is the growth rate of the Global Market for Efficacy Testing?

The growth rate of the Global Market for Efficacy Testing is 11.0%, with an estimated value of $796.7 Million by 2026.

What is the forecasted size of the Global Market for Efficacy Testing?

The Global Market for Efficacy Testing is estimated to be worth $796.7 Million by 2026.

Who are the key companies in the Global Market for Efficacy Testing?

Key companies in the Global Market for Efficacy Testing include Eurofins Scientific SE, Merck KGaA, WuXi AppTec, SGS S.A, bioMérieux and Pacific Biolabs Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • bioMérieux
  • Eurofins Scientific SE
  • Merck KGaA
  • Pacific Biolabs Inc.
  • SGS S.A
  • WuXi AppTec

I. METHODOLOGY


II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • Efficacy Testing – Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • A Prelude to Efficacy Testing
  • Global Efficacy Testing Market Poised for Steady Growth
  • US Dominates, Asia-Pacific to Witness Rapid Growth
  • Anti-microbial/Preservative Efficacy Testing to Register Rapid Growth
  • Disinfectant Efficacy Testing Dominates

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Rising Importance of Preservative Efficacy Testing
  • Challenge Organisms
  • Testing Techniques
  • Challenges
  • Conclusion
  • Preservation Technique for Paraben-Free Cosmetics
  • Development of Alternative Techniques of Preservation
  • Adoption of Hurdle Technology
  • Preservative Systems in Liquid Dietary Supplements
  • Preservative Efficacy Test (PET) for Cosmetics
  • Efficacy Testing for Cosmetics
  • Techniques Employed for Demonstrating Effectiveness of Disinfectants
  • Categorization of Test Types
  • Surface Testing
  • Additional Tests Mandated for the Pharmaceuticals Industry by the USP
  • Contact Time Defined
  • Strong Rise in Pharmaceutical Sales to Drive Demand for Efficacy Testing
  • Global Prescription Drug Sales (In US$ Billion) for the Years 2017, 2019, 2021, 2023 & 2025
  • Rapid Growth of Generic Drugs Drives Demand for Pharma Efficacy Testing
  • Global Generic Drugs Market Size (in $ Billion) for the Years 2016, 2019, 2020 & 2025
  • Aging Population Propels the Demand for Ethicacy Testing in End-use Applications
  • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Increasing Healthcare Expenditure to Foster Growth
  • World Healthcare Expenditure (In US$ Trillion) for the Years 2016 & 2018
  • Persistent Increase in Pharmaceutical R&D Bodes Well for Efficacy Testing
  • Rising Incidence of Chronic Diseases Fuels Demand for Efficacy Testing
  • Global Cancer Incidence by Region: 2018
  • Global Cancer Incidence by Type: 2018
  • Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
  • Rising Diabetes Prevalence Presents Opportunity for Cell Harvesting: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045

4. GLOBAL MARKET PERSPECTIVE

  • Consumables Segment Leads the Market

III. MARKET ANALYSIS

UNITED STATES

  • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)

CANADA

JAPAN

  • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)

CHINA

  • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)

EUROPE

  • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)

FRANCE

  • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)

GERMANY

  • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)

ITALY

UNITED KINGDOM

  • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)

SPAIN


RUSSIA


REST OF EUROPE

ASIA-PACIFIC

  • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)

AUSTRALIA

  • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)

INDIA

  • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)

SOUTH KOREA


REST OF ASIA-PACIFIC

LATIN AMERICA

  • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)

ARGENTINA


BRAZIL


MEXICO


REST OF LATIN AMERICA

MIDDLE EAST

  • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)

IRAN


ISRAEL


SAUDI ARABIA


UNITED ARAB EMIRATES


REST OF MIDDLE EAST

AFRICA

  • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)

IV. COMPETITION

  • Total Companies Profiled: 70
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Eurofins Scientific SE
  • Merck KGaA
  • WuXi AppTec
  • SGS S.A
  • bioMérieux
  • Charles River Laboratories Inc.
  • Pacific Biolabs Inc.
Note: Product cover images may vary from those shown